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OBJECTIVES: The effect of performing aortic valve repair in combination with valve-sparing operation on the
length of time for which patients are free from reoperation is unclear. The objective of this study was to determine
if the performance of aortic valve repair during valve-sparing operation modified the freedom from reopera-
tion time.
METHODS: From January 2003 to July 2014, 78 patients with a mean age of 49±15 years underwent valve-
sparing operation. Sixty-eight percent of these patients were male. Twenty-two (28%) aortic valve repair pro-
cedures were performed in this patient population. In the aortic valve repair+ valve-sparing operation group,
77.3% of patients had moderate/severe aortic insufficiency, while in the valve-sparing operation group, 58.6%
of patients had moderate/severe aortic insufficiency (ns = not significant). Additionally, 13.6% of patients in the
aortic valve repair + valve-sparing operation group had functional class III/IV, while 14.2% of patients in the
valve-sparing operation group had functional class III/IV (ns).
RESULTS: The in-hospital and late mortality rates, for the aortic valve repair + valve-sparing operation and
valve-sparing operation groups were similar, as they were 4.5% and 3.6%; and 0% and 1.8%, respectively. In the
aortic valve repair + valve-sparing operation group, 0% of patients presented moderate/severe aortic insuf-
ficiency during late follow-up, while in the valve-sparing operation group, 14.2% of patients presented with
moderate/severe aortic insufficiency during this period (ns). In the aortic valve repair+ valve-sparing operation
group, 5.3% of patients presented with functional class III/IV, while in the valve-sparing operation group,
4.2% of patients presented with functional class III/IV (ns). In the aortic valve repair + valve-sparing operation
group, 0% of patients required reoperation, while in the valve-sparing operation group, 3.6% of patients
required reoperation over a mean follow-up period of 1621±1156 days (75 patients).
CONCLUSION: Valve-sparing operation is a safe and long-lasting procedure and performance of aortic valve
repair when necessary does not increase risk of reoperation on the aortic valve.
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’ INTRODUCTION
The worldwide incidence and prevalence of thoracic aortic
disease (TAD) has increased significantly during the last two
decades, a finding that constrasts with those pertaining to
abdominal aortic disease (1).
In São Paulo State, Dias et al. performed an epidemio-
logical study on TAD, during which they observed a significant
reduction in TAD-related mortality. However, these authors
also found that there is a lack of information regarding the
incidence and prevalence of TAD disease, whose mortality rate
is high. Moreover, they noticed that patients with TAD are
extremely difficult to manage, since local centers are often
unable to effectively treat these patients, the referral of affected
patients to centers specializing in TAD treatment is inefficient
and the results of treatment provided by the centers to which
patients are referred are often suboptimal (2).
The majority of patients with TAD suffer from diseases
affecting the aortic root/ascending aorta. Aortic root recon-
struction with a composite mechanical aortic valve graft is
the operation most frequently performed for diseases of this
segment of the aorta; however, much has been written about
the aortic root replacement through valve-sparing opera-
tion (VSO) and the major difficulties related to the technicalDOI: 10.6061/clinics/2017(04)03
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complexity and reproducibility of the procedure, as well as
the benefits of preserving the native valve and the advan-
tages of non-anticoagulation afforded to patients treated
with VSO (3).
It is known that, when aortic root dilation occurs, aortic
valve insufficiency secondary to annulus dilatation is usually
observed. However, dysfunction of one or more leaflets of
the aortic valve is also often present, with prolapse of the
cusps into the left ventricle resulting in aortic regurgitation.
This phenomenon is a frequent cause of valve failure and
should be addressed when the aortic root is reconstructed
during VSO. Thus, many have questioned whether perfor-
mance of valve repair during VSO can compromise the
longevity of the procedure free from reoperation (4).
The results of an echocardiographic analysis of the pre-
dictors of residual aortic regurgitation or recurrence of aortic
insufficiency after VSO demonstrated that eccentric jets of
aortic regurgitation, effective heights of the low free edges of
valve cusps in relation to ventricular-aortic junction (VAJ)
and contact between the low free edges of opposing leaflets
below the VAJ are the predictors of immediate aortic insuf-
ficiency or during the early follow-up period and therefore
should be properly evaluated during surgery (5).
Since VSO is considered the procedure of choice for
treating aortic root disease (3,6,7), we recognize the necessity
of demonstrating that performance of aortic valve repair
(AVR) during VSO does not compromise the longevity of the
procedure and does not affect the freedom from reoperation
rate during follow-up. Therefore, the aim of this study was to
evaluate whether performance of AVR during VSO changed
the length of time for which patients are free from aortic
valve reoperation.
’ METHODS
From January 2003 to July 2014, 78 patients with or with-
out aortic valve insufficiency underwent aortic root recon-
struction using the VSO technique. Fifty-five patients underwent
VSO using the reimplantation technique (70.5%), and 23 under-
went VSO using the remodeling technique. Both groups were
assessed together to evaluate the longevity of the procedure
and were compared regarding their levels of aortic valve fail-
ure and their need for AVR (rather than being assessed as
separate remodeling technique and reimplantation technique
groups).
The patients were divided into two groups for analysis.
Group 1 consisted of patients who underwent VSO without
AVR (56 patients - 71.2%) and group 2 consisted of patients
who underwent AVR+ VSO (22 patients - 28.2%). Nineteen
patients of group 2 underwent aortic root reconstruction
using the reimplantation technique (86.4%).
Regarding aortic valve insufficiency etiologies, most cases
of aortic valve regurgitation had developed secondary to
annulus dilatation, aortic root enlargement or leaflet prolapse.
The demographic characteristics of the sample are com-
paratively listed in Table 1.
The choice to use one technique or the other for aortic root
reconstruction was based on time more than on clinical
motivation. Currently, the reimplantation technique is pre-
ferred due to the possibility that valve components can be
fixed to a polyester tube, regardless of the presence of a
genetic syndrome or acquired disease.
The cardiopulmonary bypass and myocardial ischemia
times, as well as the frequencies with which associated
procedures were performed, were similar between the two
groups (Table 2).
Patients were followed-up prospectively and evaluated
annually via transthoracic echocardiography studies. The
mean follow-up time was 1621±1156 days and clinical and
echocardiographic follow-up assessments were performed
for 98.7% and 86.7% of patients in the AVR+ VSO and VSO
groups, respectively.
The study was approved by the Scientific and Ethics
Committee of our institution and the requirement of written
informed consent was waived, based on the characteristics of
the study.
Statistical analysis
The results were expressed as the mean±SD and as per-
centages.
In the analysis, the normality assumption was verified by
the Kolmogorov-Smirnov test and visual data analysis.
When paired, continuous data were compared using
Student’s t test, and when not paired, continuous data were
compared using the Mann-Whitney U test. Categorical data
were analyzed using a chi-square test or Fisher’s exact test.
Kaplan-Meier curves and the log-rank test were used to
compare the survival rates of the VSO and AVR + VSO
groups.
Propensity score: to reduce the bias resulting from the non-
random collection of data at different times, balance the
characteristics of the sample and comparatively analyze the
patients who underwent reimplantation operations with and
without AVR, we combined the 19 patients from the VSO
and AVR + VSO groups into one group and evaluated the
patients who underwent reimplantation technique using a
propensity score, which was defined as the conditional
probability of being treated. The most relevant confounding
factors (age, left ventricular ejection fraction, degree of aortic
insufficiency and classification of heart failure according to
the New York Heart Association) were entered as predictors,
and the corresponding tolerance margin was 0.05 of logit (the
degree of aortic insufficiency and severity of heart failure
according to the New York Heart Association classification
could not be used since there was no significant associa-
tion between these parameters and the probability of being
treated, which prevented the use of the logistic regression
model).
Differences were considered significant for po0.05. All
analyses were performed using IBM software - SPSS (version 21,
IBM Corp. Armonk, NY, USA).
’ RESULTS
With the exception of age, as we observed that patients
undergoing AVR + VSO were older than patients under-
going VSO, the two groups were similar with respect to their
clinical characteristics, such as their etiopathogenesis of
aortic disease, their degrees of aortic insufficiency, their left
ventricular ejection functions, their aortic sizes, their medical
histories, their operative times and their associated proce-
dures’s complexities (Tables 1 and 2).
In-hospital mortality and immediate postoperative
complications
In-hospital mortality occurred in three patients (3.8%),
including two in the VSO group and one in the AVR+ VSO
group (ns).
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The main in-hospital complications were infection, which
occurred in 22 patients (28%), including 9 patients who devel-
oped pneumonia, 5 patients who developed sepsis, 4 patients
who developed superficial wound infections, 2 patients who
developed tracheobronchitis and 2 patients who developed
urinary tract infection; arrhythmias, particularly atrial fibrilla-
tion, which occurred in 11 patients (14%); and reoperations,
which occurred in 9 patients (11.5%), including 6 patients who
presented bleeding, one patient who developed cardiac tam-
ponade and 2 patients who required compression bandages
removal (Table 3). There were no significant differences in the
incidences of these complications between the two groups.
Late mortality
Two deaths occurred (2.6%) during the late follow-up
period (both patients underwent VSO using the remodeling
technique, without AVR). The first death, occurred secondary
to acute myocardial infarction three years after surgery,
and the second death occurred secondary to infective endo-
carditis eight years and four months after the procedure,
(the patient was referred from another institution and was
deemed unsuitable for surgery due to his poor clinical
condition when he presented to our facility) (Table 4).
Echocardiographic evaluation and functional class
Despite the significant difference between the two groups
with respect to the time at which the patients underwent
their echocardiographic evaluations, 100% of patients who
underwent AVR + VSO presented with mild aortic valve
regurgitation or less, while 77.8% of patients who underwent
VSO presented mild aortic regurgitation or less (ns). In addi-
tion, 73.7% of patients in the AVR + VSO group presented
Table 1 - Preoperative characteristics of the patients in the AVR and non-AVR groups. The patients were paired according to their
propensity scores.
Original Cohort Paired Cohort
Repair Repair
Variables No (n=56) Yes (n=22) p No (n=56) Yes (n=22) p
Mean age, years (mean ± SD) 48+15 56+14 0.046 57+14 57+14 0.991
Male, n (%) 38 (67.9) 14 (63.6) 0.722 14 (73.7) 12 (63.2) 0.485
BMI, kg/m2 (mean ± SD) 24+5 26+4 0.283 26+4 26+4 0.696
LVEF, % (mean ± SD) 0.61+0.10 0.61+0.10 0.944 0.57+0.09 0.60+0.10 0.258
LVEDV, (mean ± SD) 201+108 232+64 0.463 207+56 234+67 0.245
Aortic diameter, mm (mean ± SD) 56+9 56+7 0.954 57+9 57+7 0.951
Risk factor
Marfan syndrome, n (%) 11 (19.6) 1 (4.6) 0.162 1 (5.3) 1 (5.3) 1.000
Bicuspid aortic valve, n (%) 3 (5.4) 1 (4.6) 1.000 - - -
Tricuspid aortic valve, n (%) 52 (92.9) 21 (95.5) 1.000 18 (94.7) 19 (100.0) 1.000
Hypertension, n (%) 42 (75.0) 18 (81.8) 0.520 16 (84.2) 15 (79.0) 1.000
Diabetes mellitus, n (%) 5 (8.9) 4 (4.6) 0.670 3 (15.8) 1 (5.3) 0.604
Dyslipidemia, n (%) 9 (16.1) 5 (22.7) 0.522 4 (21.1) 5 (26.3) 1.000
Hypothyreoidism, n (%) 1 (1.8) 1 (4.6) 0.487 1 (5.3) 1 (5.3) 1.000
Acute RF, n (%) 2 (3.6) 0 (0.0) 1.000 2 (10.5) 0 (0.0) 0.487
Chronic RF, n (%) 2 (3.6) 2 (9.1) 0.315 1 (5.3) 2 (10.5) 1.000
Dialytic RF, n (%) 1 (1.8) 0 (0.0) 1.000 - - -
Smoking, n (%) 22 (39.3) 11 (50.0) 0.389 9 (47.4) 10 (52.6) 0.746
Family history, n (%) 6 (10.7) 1 (4.6) 0.666 0 (0.0) 1 (5.3) 1.000
COPD, n (%) 2 (3.6) 2 (9.1) 0.315 1 (5.3) 1 (5.3) 1.000
Cancer, n (%) 1 (1.8) 0 (0.0) 1.000 1 (5.3) 0 (0.0) 1.000
Dyspepsia, n (%) 9 (16.1) 3 (13.6) 1.000 1 (5.3) 2 (10.5) 1.000
Coronary insufficiency , n (%) 8 (14.3) 6 (27.3) 0.201 4 (21.1) 5 (26.3) 1.000
Prior MI, n (%) 1 (1.8) 0 (0.0) 1.000 - - -
Chest pain, n (%) 19 (33.9) 9 (40.9) 0.563 7 (36.8) 8 (42.1) 0.740
Prior atrial fibrillation, n (%) 0 (0.0) 1 (4.6) 0.282 0 (0.0) 1 (5.3) 1.000
Cardiac insufficiency, n (%) 0.507 1.000
FC I, n(%) 36 (64.3) 12 (54.6) 11 (57.9) 11 (57.9)
FC II, n (%) 12 (21.4) 8 (36.4) 6 (31.6) 7 (36.8)
FC III, n (%) 6 (10.7) 2 (9.1) 2 (10.5) 1 (5.3)
FC IV, n (%) 2 (3.6) 0 (0.0) 0 (0.0) 0 (0.0)
Indication for surgery, n (%)
Aneurysm 53 (94.6) 21 (95.5) 1.000 19 (100) 18 (94.7) 1.000
Type A chronic dissection 4 (7.1) 1 (4.6) 1.000 0 (0.0) 1 (5.3) 1.000
Aortic valve function, n (%) 0.384 0.489
absent AI 5 (9.3) 0 (0.0) 0 (0.0) 0 (0.0)
minimum AI 2 (3.7) 0 (0.0) 0 (0.0) 0 (0.0)
discrete AI 15 (27.8) 5 (22.7) 4 (21.1) 3 (15.8)
moderate AI 16 (29.6) 6 (27.3) 9 (47.4) 6 (31.6)
severe AI 16 (29.6) 11 (50.0) 6 (31.6) 10 (52.6)
Urgent/emergency surgery, n (%) 0 (0.0) 1 (4.6) 0.282 0 (0.0) 1 (5.3) 1.000
AVR=aortic valve repair; BMI=body mass index; COPD=chronic obstructive pulmonary disease; FC=functional class (New York Heart Association); LVEF=left
ventricular ejection fraction; LVEDV=left ventricular end-diastolic volume; MI=myocardial infarction; RF=renal failure; SD=standard deviation.
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with heart failure class II or less, while 52.1% of patients in
the VSO presented with heart failure functional class II or
less (ns) (Table 4).
Survival and freedom from reoperation for aortic
valve failure
Despite the significant difference between the two groups
with respect to the follow-up times during which patients
underwent AVR+ VSO and VSO were evaluated, there was
no difference in late survival between the groups, regardless
of the surgical technique utilized (Figure 1A and 1B).
The freedom from reoperation rates were also similar
between the groups (despite the difference in follow-up time
between them). Only one patient underwent reoperation
for aortic valve replacement. This procedure was performed
four years after VSO without AVR operation (which was
performed with the reimplantation technique) and the post-
operative course was uneventful (Figure 2A and 2B).
’ DISCUSSION
Whenever possible, VSO must be considered and per-
formed, regardless of patient age and aortic disease etio-
pathogenesis, as the literature has consistently reported that
patients who undergo VSO experience fewer complications
related to anticoagulation or reoperations because of infec-
tion or prosthesis dysfunction than patients who undergo the
Bentall procedure (6).
VSO requires knowledge of the complex anatomy of the
functional aortic root and the relationship between its valve
leaflets and the aortic wall and adjacent tissues, a portion of
which are fibrous (fibrous skeleton of the heart) and another
portion of which are muscular (interventricular septum). It is
Table 2 - Intraoperative variables of the patients in the AVR and non-AVR groups. The patients were paired according to their
propensity scores.
Original Cohort Paired Cohort
Repair Repair
Variables No (n=56) Yes (n=22) p No (n=19) Yes (n=19) p
Time of CPB, min (mean±SD) 155±35 159±28 0.585 163±32 165±24 0.768
Time of myocardial ischemia, min (mean±SD) 133±29 139±23 0.369 139±25 145±17 0.458
Aortic Approach 0.054 -
Reimplantation 36 (64.3) 19 (86.4)
Remodeling 20 (35.7) 3 (13.6)
Associated Procedures, n (%)
CABG, n (%) 5 (8.9) 1 (4.6) 0.670 2 (10.5) 1 (5.3) 1.000
Mitral Replacement/Repair, n (%) 1 (1.8) 2 (9.1) 0.190 0 (0.0) 2 (10.5) 0.487
AVR=aortic valve repair; CABG=coronary artery bypass grafting; CPB=cardiopulmonary bypass; SD=standard deviation.
Table 3 - In-hospital postoperative outcomes of the patients in the AVR and non-AVR groups. The patients were paired according to
their propensity scores.
Original Cohort Paired Cohort
Repair Repair
Variables No (n=56) Yes (n=22) p No (n=19) Yes (n=19) p
Reoperation, n (%)
Bleeding 4 (7.1) 2 (9.1) 1.000 4 (21.1 2 (10.5) 0.660
Tamponade 0 (0.0) 1 (4.6) 0.282 0 (0.0) 1 (5.3) 1.000
Compresses removal 2 (3.6) 0 (0.0) 1.000 2 (10.5) 0 (0.0) 0.487
Other Complications n (%)
Low debit 1 (1.8) 0 (0.0) 1.000 - - -
Wound infection 2 (3.6) 2 (9.1) 0.315 1 (5.3) 2 (10.5) 1.000
Tracheobronchitis 2 (3.6) 0 (0.0) 1.000 2 (10.5) 0 (0.0) 0.487
Pneumonia 6 (10.7) 3 (13.6) 0.706 2 (10.5) 2 (10.5) 1.000
UTI 1 (1.8) 1 (4.6) 0.487 0 (0.0) 1 (5.3) 1.000
Sepsis 3 (5.4) 2 (9.1) 0.617 2 (10.5) 2 (10.5) 1.000
ARF 2 (3.6) 0 (0.0) 1.000 2 (10.5) 0 (0.0) 0.487
Psychomotor agitation 0 (0.0) 1 (4.6) 0.282 0 (0.0) 1 (5.3) 1.000
Delirium 0 (0.0) 1 (4.6) 0.282 0 (0.0) 1 (5.3) 1.000
Stroke (permanent deficit) 1 (1.8) 0 (0.0) 1.000 - - -
AMI 1 (1.8) 0 (0.0) 1.000 - - -
Mesenteric ischemia 0 (0.0) 1 (4.6) 0.282 0 (0.0) 1 (5.3) 1.000
Atrial arrhythmias 9 (16.1) 2 (9.1) 0.719 4 (21.1) 1 (5.3) 0.340
Death n (%)
Hospital death 2 (3.6) 1 (4.6) 1.000 1 (5.3) 1 (5.3) 1.000
30-days 2 (3.6) 1 (4.6) 1.000 1 (5.3) 1 (5.3) 1.000
AMI=acute myocardial infarction; ARF=acute renal failure; AVR=aortic valve repair; UTI=urinary tract infection.
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Table 4 - Late postoperative data for the patients in the AVR and non-AVR groups. The patients were paired according to their
propensity scores.
Original Cohort Paired Cohort
Repair Repair
Variables No (n=54) Yes (n=21) p No (n=19) Yes (n=19) p
Thromboembolic complications, n (%) 1 (1.8) 0 (0.0) 1.000 - - -
Endocarditis, n (%) 1 (1.8) 0 (0.0) 1.000 - - -
Late reoperation, n (%) 1 (1.8) 0 (0.0) 1.000 - - -
Time between pre and final
echocardiogram (in months) 48 13 23 14
Median (25 - 75%) (18-84) (9-18) 0.002 (8-72) (9-20) 0.275
LVEF (mean±SD) 0.61±0.08 0.59±0.11 0.434 0.58±0.11 0.58±0.12 0.910
LVEDV (mean±SD) 155±85 142±65 0.589 141±48 141±69 0.765
Late cardiac insufficiency, n (%) 0.129 0.250
FC I 0 (0.0) 1 (5.3)
FC II 25 (52.1) 13 (68.4) 8 (53.3) 13 (81.3)
FC III 21 (43.8) 4 (21.1) 6 (40.0) 2 (12.5)
FC IV 0 (0.0) 0 (0.0) 1 (6.7) 1 (6.3)
Aortic valve function, n (%) 0.208 0.536
absent AI 7 (15.6) 2 (11.1) 1 (8.3) 2 (12.5)
minimum AI 4 (8.9) 4 (22.2) 1 (8.3) 4 (25.0)
discrete AI 24 (53.3) 12 (66.7) 9 (75.0) 10 (62.5)
moderate AI 6 (13.3) 0 (0.0) 0 (0.0) 0 (0.0)
severe AI 4 (8.9) 0 (0.0) 1 (8.3) 0 (0.0)
Follow-up time (in months) 50 3 28 3
Median (15-81) (2-34) o 0.001 (8-50) (2-34) 0.073
Death (30 days or more of follow-up) 4 (7.1) 1 (4.6) 1.000 1 (5.3) 1 (5.3) 1.000
AVR=aortic valve repair; FC=functional class (New York Heart Association); LVEF=left ventricular ejection fraction; LVEDV=left ventricular end-diastolic
volume; SD=standard deviation.
Figure 1 - Fig 1A: Survival curves of the patients (Kaplan-Meier) undergoing aortic root reconstruction through AVR and non-AVR
techniques. Fig 1B: Survival curves of the patients (Kaplan-Meier) undergoing aortic root reconstruction. The patients were paired
according to their propensity scores.AVR=aortic valve repair; VSO=valve-sparing operation.
Figure 2 - Fig 2A: Freedom from reoperation curve (Kaplan-Meier) pertaining to the aortic valves of the patients undergoing aortic root
reconstruction through AVR and non-AVR techniques. Fig 2B: Freedom from reoperation curve (Kaplan-Meier) pertaining to the aortic
valves of the patients undergoing aortic root reconstruction. The patients were paired according to their propensity scores.AVR=aortic valve
repair; VSO=valve-sparing operation.
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also crucial to determine the size of the aortic annulus, the
location of the VAJ, the effective and geometric heights of the
valve leaflets, the ideal levels and areas of cusp coaptation, and
the height at which coaptation occurs relative to the location of
the VAJ, as well as to understand the importance of the sino-
tubular junction and its height relative to that of the aortic annulus.
The main mechanisms underlying the development of
aortic valve insufficiency are related to primary changes
in the valve leaflets or to secondary changes imposed by
aortic diseases, as stated in the classification proposed by El
Khoury et al., which proposes the performance of specific
repair procedures for each of these situations (8).
Currently, valve-sparing aortic root reconstruction opera-
tions are considered the procedures of choice for treating aortic
root diseases because they enable native valve preservation.
When necessary, however, additional procedures involving
the aortic valve cusps may be performed if the leaflets are
responsible for causing aortic regurgitation (3,7,9).
Albes, Stock and Hartrumpf reported a meta-analysis in
which they found that performing VSO using the reimplanta-
tion technique, as proposed by David and Feindel (10), when
aortic root reconstruction is necessary is associated with
greater longevity, particularly if performed in patients with
congenital abnormalities of the aortic wall, while performing
VSO using the remodeling technique, as proposed by Yacoub
et al. (11), seems to preserve the physiology of the spared
valve more faithfully than the reimplantation procedure (12).
However, whether performing AVR along with VSO is a
risk factor with respect to the longevity of the valve-sparing
procedure remains controversial (13,14).
Thus, we developed this study, as our previous experience
with VSO demonstrated that we could safely extend the
operation for patients with primary valvular insufficiency
(with or without aortic root dilation). For this reason, this
subgroup of patients had a shorter follow-up time than the
subgroup of patients who underwent VSO only.
The mortality rate was low in both groups, which did not
differ with respect to other outcome parameters, findings
similar to those reported in the literature. Additionally, it
should be emphasized that 77% of patients who underwent
valve repair presented moderate or severe aortic insuffi-
ciency on preoperative echocardiography (50% of patients
had severe disease) and that no major insufficiencies were
noted on the postoperative studies of these patients (i.e., zero
patients had worse than mild valve regurgitation).
The limitations of this study were mainly related to the
small sample of patients who underwent VSO at our facility,
the small number of patients who underwent valve repair
procedures and the short follow-up time during which this
subgroup of patients was assessed.
Despite the abovementioned limitations, we can conclude
that VSO is a safe and long-lasting procedure and performance
of AVR when necessary does not increase the risk of late
reoperation on the aortic valve.
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